NR3C2 Sequencing
method(s): ◦ Sequencing, Capillary (Sanger)
Center for Nephrology and Metabolic Disorders, Laboratory for Molecular Diagnostics - Weisswasser, Germany |
Bartter Syndrome, Panel Massive Sequencing (NGS) 23 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Autosomal Dominant Pseudohypoaldosteronism Type 1 , Sequencing NR3C2 Gene
method(s): ◦ Sequencing, Capillary (Sanger)
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Ion Channel Disorders Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Kidney Diseases Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
TAT: 4 weeks
price: $2,600.00
Pseudohypoaldosteronism Type 1 NGS Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Johns Hopkins Hospital, DNA Diagnostic Laboratory - Baltimore, MD, USA |
Pseudohypoaldosteronism type I (sequence analysis of NR3C2 gene)
method(s): ◦ Sequencing, Capillary (Sanger)
CGC Genetics - Porto, Portugal |
Bartter Syndrome
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Pseudohypoaldosteronism Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
TAT: 11-12 weeks
price: $2,000.00
KidneySeq - A Comprehensive Inherited Kidney Disease Panel
method(s): ◦ Sequencing, Next Gen
Iowa Institute of Human Genetcs (IIHG) - Iowa City, IA, USA |
Pseudohypoaldosteronism, Panel Massive Sequencing (NGS) 9 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
NR3C2
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Fulgent Diagnostics - Temple City, CA, USA |
TAT: 3-4 weeks
price: $690.00
Autosomal Dominant Pseudohypoaldosteronism Type 1 via the NR3C2 Gene
method(s): ◦ Del/Dup (CNV)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 2-3 weeks
price: $910.00
Autosomal Dominant Pseudohypoaldosteronism Type 1 via the NR3C2 Gene
method(s): ◦ Sequencing, Capillary (Sanger)
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
Pseudohypoaldosteronism (Pseudohypoaldosteronismus)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Hypertension early onset
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Centogene AG, Rare Disease Company - Rostock, Germany |
Pseudohypoaldosteronism, type 1, autosomal dominant
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Centogene AG, Rare Disease Company - Rostock, Germany |
Bartter Syndrome panel
method(s): ◦ Del/Dup (CNV) ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
CentoICU Platinum
method(s): ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
Hereditary Hypertension
method(s): ◦ Sequencing, Capillary (Sanger)
Cologne University, Institute of Human Genetics - Cologne, Germany |
Pseudohypoaldosteronism panel
method(s): ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
Pseudohypoaldosteronism Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Pseudohypoaldosteronism Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
